The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NSCLC: Integrating the “Yale model shared decision-making solution” into the practice setting.
 
Kerin B. Adelson
Stock and Other Ownership Interests - Carrum Health; Lyra Health (I); MindNest Health (I)
Honoraria - Genentech
Consulting or Advisory Role - Celgene; HERON; Roche
Research Funding - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Genentech
Travel, Accommodations, Expenses - Celgene; Genentech; HERON; Roche
Other Relationship - Genentech/Roche
 
Roy S. Herbst
Leadership - Junshi Pharmaceuticals
Consulting or Advisory Role - Abbvie; ARMO Biosciences; AstraZeneca; Biodesix; Bolt Biotherapeutics; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Genmab; Halozyme; Heat Biologics; I-Mab; Immunocore; Infinity Pharmaceuticals; Junshi Pharmaceuticals; Lilly; Loxo; Merck; Midas Health Analytics; Mirati Therapeutics; Nektar; Neon Therapeutics; NextCure; Novartis; Pfizer; Sanofi; Seagen; Shire; Spectrum Pharmaceuticals; Symphogen; Takeda; TESARO; Tocagen
Research Funding - AstraZeneca; Genentech/Roche; Lilly; Merck
 
Patricia Peterson
No Relationships to Disclose
 
Michele Ingram
No Relationships to Disclose
 
Brant J. Oliver
Research Funding - Biogen
 
Tarjani Agrawal
No Relationships to Disclose
 
Marianne Davies
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck
 
Elaine Rudell
No Relationships to Disclose